Literature DB >> 23946870

Phenothiazine Inhibitors of TLKs Affect Double-Strand Break Repair and DNA Damage Response Recovery and Potentiate Tumor Killing with Radiomimetic Therapy.

Sharon Ronald1, Sanket Awate, Abhijit Rath, Jennifer Carroll, Floyd Galiano, Donard Dwyer, Heather Kleiner-Hancock, J Michael Mathis, Simone Vigod, Arrigo De Benedetti.   

Abstract

The Tousled-like kinases (TLKs) are involved in chromatin assembly, DNA repair, and transcription. Two TLK genes exist in humans, and their expression is often dysregulated in cancer. TLKs phosphorylate Asf1 and Rad9, regulating double-strand break (DSB) repair and the DNA damage response (DDR). TLKs maintain genomic stability and are important therapeutic intervention targets. We identified specific inhibitors of TLKs from several compound libraries, some of which belong to the family of phenothiazine antipsychotics. The inhibitors prevented the TLK-mediated phosphorylation of Rad9(S328) and impaired checkpoint recovery and DSB repair. The inhibitor thioridazine (THD) potentiated tumor killing with chemotherapy and also had activity alone. Staining for γ-H2AX revealed few positive cells in untreated tumors, but large numbers in mice treated with low doxorubicin or THD alone, possibly the result of the accumulation of DSBs that are not promptly repaired as they may occur in the harsh tumor growth environment.

Entities:  

Keywords:  DNA damage response; inhibitors of Tousled kinases; mechanism of DSB repair; radiomimetic sensitizers

Year:  2013        PMID: 23946870      PMCID: PMC3743153          DOI: 10.1177/1947601913479020

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  59 in total

1.  An analysis of CAF-1-interacting proteins reveals dynamic and direct interactions with the KU complex and 14-3-3 proteins.

Authors:  Maarten Hoek; Michael P Myers; Bruce Stillman
Journal:  J Biol Chem       Date:  2011-01-05       Impact factor: 5.157

2.  Identification of human Asf1 chromatin assembly factors as substrates of Tousled-like kinases.

Authors:  H H Silljé; E A Nigg
Journal:  Curr Biol       Date:  2001-07-10       Impact factor: 10.834

3.  DNA lesion-specific co-localization of the Mre11/Rad50/Nbs1 (MRN) complex and replication protein A (RPA) to repair foci.

Authors:  Jacob G Robison; Lu Lu; Kathleen Dixon; John J Bissler
Journal:  J Biol Chem       Date:  2005-01-14       Impact factor: 5.157

Review 4.  Antitumor potential and possible targets of phenothiazine-related compounds.

Authors:  N Motohashi; M Kawase; S Saito; H Sakagami
Journal:  Curr Drug Targets       Date:  2000-11       Impact factor: 3.465

Review 5.  Role of PARP inhibitors in cancer biology and therapy.

Authors:  D Davar; J H Beumer; L Hamieh; H Tawbi
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

6.  TLK1B promotes repair of DSBs via its interaction with Rad9 and Asf1.

Authors:  Caroline Canfield; Justin Rains; Arrigo De Benedetti
Journal:  BMC Mol Biol       Date:  2009-12-20       Impact factor: 2.946

7.  Tousled kinase TLK1B mediates chromatin assembly in conjunction with Asf1 regardless of its kinase activity.

Authors:  Arrigo De Benedetti
Journal:  BMC Res Notes       Date:  2010-03-11

8.  Genetic variation in the chromosome 17q23 amplicon and breast cancer risk.

Authors:  Linda E Kelemen; Xianshu Wang; Zachary S Fredericksen; V Shane Pankratz; Paul D P Pharoah; Shahana Ahmed; Alison M Dunning; Douglas F Easton; Robert A Vierkant; James R Cerhan; Ellen L Goode; Janet E Olson; Fergus J Couch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05-19       Impact factor: 4.254

9.  Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1.

Authors:  Darren R Krause; Jyoti C Jonnalagadda; Magtouf H Gatei; Herman H W Sillje; Bin-Bing Zhou; Erich A Nigg; Kumkum Khanna
Journal:  Oncogene       Date:  2003-09-04       Impact factor: 9.867

10.  The radioresistance kinase TLK1B protects the cells by promoting repair of double strand breaks.

Authors:  Gulshan Sunavala-Dossabhoy; Sri Kripa Balakrishnan; Siddhartha Sen; Sam Nuthalapaty; Arrigo De Benedetti
Journal:  BMC Mol Biol       Date:  2005-09-12       Impact factor: 2.946

View more
  15 in total

1.  Identification of the proteome complement of humanTLK1 reveals it binds and phosphorylates NEK1 regulating its activity.

Authors:  Vibha Singh; Zachary M Connelly; Xinggui Shen; Arrigo De Benedetti
Journal:  Cell Cycle       Date:  2017-04-20       Impact factor: 4.534

2.  Tousled kinase activator, gallic acid, promotes homologous recombinational repair and suppresses radiation cytotoxicity in salivary gland cells.

Authors:  Prakash Srinivasan Timiri Shanmugam; Renjith Parameshwaran Nair; Arrigo De Benedetti; Gloria Caldito; Fleurette Abreo; Gulshan Sunavala-Dossabhoy
Journal:  Free Radic Biol Med       Date:  2016-02-15       Impact factor: 7.376

3.  Curcumin induces apoptosis in p53-null Hep3B cells through a TAp73/DNp73-dependent pathway.

Authors:  Jinhong Wang; Hai Xie; Feng Gao; Tingkun Zhao; Hongming Yang; Bai Kang
Journal:  Tumour Biol       Date:  2015-10-22

4.  Tousled-like kinase regulates cytokine-mediated communication between cooperating cell types during collective border cell migration.

Authors:  Wenjuan Xiang; Dabing Zhang; Denise J Montell
Journal:  Mol Biol Cell       Date:  2015-10-28       Impact factor: 4.138

5.  Fidelity of end joining in mammalian episomes and the impact of Metnase on joint processing.

Authors:  Abhijit Rath; Robert Hromas; Arrigo De Benedetti
Journal:  BMC Mol Biol       Date:  2014-03-22       Impact factor: 2.946

6.  TLK1B mediated phosphorylation of Rad9 regulates its nuclear/cytoplasmic localization and cell cycle checkpoint.

Authors:  Sanket Awate; Arrigo De Benedetti
Journal:  BMC Mol Biol       Date:  2016-02-09       Impact factor: 2.946

7.  NOX4-mediated ROS production induces apoptotic cell death via down-regulation of c-FLIP and Mcl-1 expression in combined treatment with thioridazine and curcumin.

Authors:  Seung Un Seo; Tae Hwan Kim; Dong Eun Kim; Kyoung-Jin Min; Taeg Kyu Kwon
Journal:  Redox Biol       Date:  2017-08-09       Impact factor: 11.799

Review 8.  Targeting protein phosphatase PP2A for cancer therapy: development of allosteric pharmaceutical agents.

Authors:  David L Brautigan; Caroline Farrington; Goutham Narla
Journal:  Clin Sci (Lond)       Date:  2021-07-16       Impact factor: 6.876

9.  High yield bacterial expression, purification and characterisation of bioactive Human Tousled-like Kinase 1B involved in cancer.

Authors:  Siddhant Bhoir; Althaf Shaik; Vijay Thiruvenkatam; Sivapriya Kirubakaran
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

10.  Knockdown of Tousled‑like kinase 1 inhibits survival of glioblastoma multiforme cells.

Authors:  Kamariah Ibrahim; Nor Azian Abdul Murad; Roslan Harun; Rahman Jamal
Journal:  Int J Mol Med       Date:  2020-05-28       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.